NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

Shareholding Pattern: Shareholding Pattern Glenmark Life Sciences Limited An Examination of Financial Performance for FY (Q4-Mar 2023-2024)

Image is loading
Glenmark Life Sciences Limited has released its latest shareholding reports, covering the quarter and the first half of the fiscal year ending on (Q4-Mar 2023-2024).This detailed report examines who owns shares, including Promoters, promoter groups, Foreign investors, public investors, and government entities.
Shareholder Name Previous Quater Quantity(In Crores) Current Quater Quantity(In Crores) Previous Quater Shares(in %) Current Quater Shares(in %) Quater to Quater Difference
Promoters 10.15 10.15 82.85 82.85 0
Public 2.10 2.10 11.84 10.74 -1.1 %
DII 0.09 0.17 0.74 1.4 +0.66 %
FII 0.56 0.61 4.57 5.01 +0.44 %
Government 0 0 0 0 0
Promoters shareholding remained stable, at 82.85% in both December 2023 and March 2024. This indicates that the promoters’ control over the company did not change during this period. The percentage of shares held by the public decreased from 11.84% in December 2023 to 10.74% in March 2024.This reduction indicates that the public’s stake in the company diminished during this period.DIIs (Domestic Institutional Investors) shareholding increased from 0.74% in December 2023 to 1.4% in March 2024 , indicating that domestic institutions increased their stake in the company by 0.66% . FIIs (Foreign Institutional Investors): There was a significant increase from 4.57% in December 2023 to 5.01% in March 2024. This suggests that foreign institutions grew their investments 0.44 in the company during the quarter.

Let’s look into the statistics of the investors, which could have contributed to the fluctuations in the shareholding pattern.

Shareholder Name Previous Quarter Quantity (In crores) Current Quarter Quantity (In crores) Previous Quarter Shares (in %) Current Quarter Shares (in %) Quarter-to-Quarter Difference (%)
GLENMARK PHARMACEUTICALS LIMITED 10.150 0.961 82.84 7.84 -75 %
NIRMA LIMITED 0 9.190 0 75 +75%
GLENMARK PHARMACEUTICALS LIMITED faced a downturn in stakeholding this quarter, witnessing a decline of -75 % in stakeholding compared to the previous quarter.NIRMA LIMITED had no shares in the previous quarter but now holds 75% of shares in the current quarter.
Shareholder Name Previous Quarter Quantity (In Crores) Current Quarter Quantity (In Crores) Previous Quater Shares (in %) Current Quater Shares (in %) Quater-to-Quater Difference (%)
Resident Individuals holding nominal share capital up to Rs. 2 lakhs 1.050 1.037 8.57 8.46 -0.11 %
Non Resident Indians (NRIs) 0.051 0.065 0.42 0.53 + 0.11 %
Bodies Corporate 0.239 0.108 1.95 0.88 -1.07 %
Any Other (specify) 0.033 0.028 0.27 0.23 -0.04 %
Trusts 0.001 0.000 0.01 0 -0.01 %
HUF 0.032 0.028 0.26 0.23 -0.03 %
Observations show a significant difference of -0.11 % in Resident Individuals holding nominal share capital up to Rs. 2 lakhs’s financial performance between quarters.Leading the way to higher stakeholding, Non Resident Indians (NRIs) has significantly boosted stakeholding by an impressive 0.11 %.Observations show a significant difference of -1.07 % in Bodies Corporate’s financial performance between quarters.Observations show a significant difference of -0.04 % in Any Other (specify)’s financial performance between quarters.Observations show a significant difference of -0.01 % in Trusts’s financial performance between quarters.Observations show a significant difference of -0.03 % in HUF’s financial performance between quarters.
Shareholder Name Previous Quarter Quantity (In Crores) Current Quarter Quantity (In Crores) Previous Quater Shares (in %) Current Quater Shares (in %) Quater-to-Quater Difference (%)
Mutual Funds/ 0.072 0.114 0.59 0.93 + 0.34 %
Alternate Investment Funds 0.018 0.058 0.15 0.48 + 0.33 %
The latest quarter saw a considerable enhancement in stakeholding for Mutual Funds/, reflecting an uptick of 0.34 % in their shares.The latest quarter saw a considerable enhancement in stakeholding for Alternate Investment Funds, reflecting an uptick of 0.33 % in their shares.
Shareholder Name Previous Quarter Quantity (In Crores) Current Quarter Quantity (In Crores) Previous Quater Shares (in %) Current Quater Shares (in %) Quater-to-Quater Difference (%)
Foreign Portfolio Investors Category I 0.532 0.576 4.34 4.7 + 0.36 %
Foreign Portfolio Investors Category II 0.028 0.039 0.23 0.31 + 0.08 %
During this past quarter, there was a noteworthy upswing in stakeholding for Foreign Portfolio Investors Category I, which experienced a significant increase of 0.36 % .During this past quarter, there was a noteworthy upswing in stakeholding for Foreign Portfolio Investors Category II, which experienced a significant increase of 0.08 % .
[my_shortcode1 values=”Glenmark Life Sciences Limited “]

Related Post